Literature DB >> 10094783

Viral protease assay based on GAL4 inactivation is applicable to high-throughput screening in mammalian cells.

J F Lawler1, S H Snyder.   

Abstract

We present an assay for viral proteases that relies on the proteolytic cleavage of substrate leading to the dissociation of the yeast transcription factor GAL4. A consensus substrate for the cytomegalovirus protease is fused between the DNA binding and transactivating domains of GAL4. Proteolysis inactivates the transcription factor which drives a luciferase reporter system. The assay is performed in mammalian cells, has a robust signal-to-noise ratio, and assesses proteolysis in a physiologic context. A unique feature of the assay is its ability to detect inhibitors of viral replication that act on viral targets other than the protease. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094783     DOI: 10.1006/abio.1999.4017

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  1 in total

1.  Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format.

Authors:  Valérie Cottier; Alcide Barberis; Urs Lüthi
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.